RSK inhibition has been reported to reversibly inhibit proliferation of tumor derived cell lines and indeed all three inhibitor concentrations stopped the growth of both BC3 PEL cells and BJAB B cells (Figure 9A). This evidence concerns the gene RPS6KA1 and neoplasm.